A citation-based method for searching scientific literature

Scott D Grosse, Sarah Wordsworth, Katherine Payne. Genet Med 2008
Times Cited: 76







List of co-cited articles
381 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Challenges of translating genetic tests into clinical and public health practice.
Wolf H Rogowski, Scott D Grosse, Muin J Khoury. Nat Rev Genet 2009
77
18

What is the clinical utility of genetic testing?
Scott D Grosse, Muin J Khoury. Genet Med 2006
173
17

Economic analyses of human genetics services: a systematic review.
Josh J Carlson, Nora Beidler Henrikson, David L Veenstra, Scott D Ramsey. Genet Med 2005
41
31


The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.
Steven M Teutsch, Linda A Bradley, Glenn E Palomaki, James E Haddow, Margaret Piper, Ned Calonge, W David Dotson, Michael P Douglas, Alfred O Berg. Genet Med 2009
464
14

Personal utility and genomic information: look before you leap.
Scott D Grosse, Colleen M McBride, James P Evans, Muin J Khoury. Genet Med 2009
56
19

Population screening for genetic disorders in the 21st century: evidence, economics, and ethics.
S D Grosse, W H Rogowski, L F Ross, M C Cornel, W J Dondorp, M J Khoury. Public Health Genomics 2010
84
13

Evaluating the utility of personal genomic information.
Morris W Foster, John J Mulvihill, Richard R Sharp. Genet Med 2009
124
13


Valuing the economic benefits of complex interventions: when maximising health is not sufficient.
Katherine Payne, Marion McAllister, Linda M Davies. Health Econ 2013
70
14


Outcome measurement in clinical genetics services: a systematic review of validated measures.
Katherine Payne, Stuart Nicholls, Marion McAllister, Rhona Macleod, Dian Donnai, Linda M Davies. Value Health 2008
70
11

Understanding the medical and nonmedical value of diagnostic testing.
David W Lee, Peter J Neumann, John A Rizzo. Value Health 2010
40
20

Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents.
Peter J Neumann, Joshua T Cohen, James K Hammitt, Thomas W Concannon, Hannah R Auerbach, Chihui Fang, David M Kent. Health Econ 2012
83
10

Points to consider in assessing and appraising predictive genetic tests.
Wolf H Rogowski, Scott D Grosse, Jürgen John, Helena Kääriäinen, Alastair Kent, Ulf Kristofferson, Jörg Schmidtke. J Community Genet 2010
19
42


EuroGentest: DNA-based testing for heritable disorders in Europe.
Poupak Javaher, Helena Kaariainen, Ulf Kristoffersson, Irmgard Nippert, Jorge Sequeiros, Ron Zimmern, Jorg Schmidtke. Community Genet 2008
22
31


Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.
Rena Conti, David L Veenstra, Katrina Armstrong, Lawrence J Lesko, Scott D Grosse. Med Decis Making 2010
67
10

Issues surrounding the health economic evaluation of genomic technologies.
James Buchanan, Sarah Wordsworth, Anna Schuh. Pharmacogenomics 2013
62
11


Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.
Eric Faulkner, Lieven Annemans, Lou Garrison, Mark Helfand, Anke-Peggy Holtorf, John Hornberger, Dyfrig Hughes, Tracy Li, Daniel Malone, Katherine Payne,[...]. Value Health 2012
75
8

Willingness to pay for diagnostic technologies: a review of the contingent valuation literature.
Pei-Jung Lin, Michael J Cangelosi, David W Lee, Peter J Neumann. Value Health 2013
35
17

How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom.
Simon Sanderson, Ron Zimmern, Mark Kroese, Julian Higgins, Christine Patch, Jon Emery. Genet Med 2005
73
6




Genetic health technology and economic evaluation: a critical review.
James Jarrett, Miranda Mugford. Appl Health Econ Health Policy 2006
15
33

Welfarism vs. extra-welfarism.
Werner B F Brouwer, Anthony J Culyer, N Job A van Exel, Frans F H Rutten. J Health Econ 2008
143
6

Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force.
F Reed Johnson, Emily Lancsar, Deborah Marshall, Vikram Kilambi, Axel Mühlbacher, Dean A Regier, Brian W Bresnahan, Barbara Kanninen, John F P Bridges. Value Health 2013
614
6

Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.
Katharina Schwarze, James Buchanan, Jenny C Taylor, Sarah Wordsworth. Genet Med 2018
185
6

Replication validity of genetic association studies.
J P Ioannidis, E E Ntzani, T A Trikalinos, D G Contopoulos-Ioannidis. Nat Genet 2001
5


On the testing load incurred by cascade genetic carrier screening for Mendelian disorders: a brief report.
Michael Krawczak, Amke Caliebe, Peter J P Croucher, Jörg Schmidtke. Genet Test 2007
6
66



Value of information on preference heterogeneity and individualized care.
Anirban Basu, David Meltzer. Med Decis Making 2007
81
5

The efficacy of diagnostic imaging.
D G Fryback, J R Thornbury. Med Decis Making 1991
843
5

Genetic test evaluation: information needs of clinicians, policy makers, and the public.
Wylie Burke, David Atkins, Marta Gwinn, Alan Guttmacher, James Haddow, Joseph Lau, Glenn Palomaki, Nancy Press, C Sue Richards, Louise Wideroff,[...]. Am J Epidemiol 2002
118
5

Economic considerations for health insurance coverage of emerging genetic tests.
Mita Giacomini, Fiona Miller, Bernie J O'Brien. Community Genet 2003
17
23


Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.
David T Miller, Margaret P Adam, Swaroop Aradhya, Leslie G Biesecker, Arthur R Brothman, Nigel P Carter, Deanna M Church, John A Crolla, Evan E Eichler, Charles J Epstein,[...]. Am J Hum Genet 2010
5


Bayesian and classical estimation of mixed logit: An application to genetic testing.
Dean A Regier, Mandy Ryan, Euan Phimister, Carlo A Marra. J Health Econ 2009
31
12


Outcome measures for clinical genetics services: a comparison of genetics healthcare professionals and patients' views.
Katherine Payne, Stuart G Nicholls, Marion McAllister, Rhona MacLeod, Ian Ellis, Dian Donnai, Linda M Davies. Health Policy 2007
36
11

Evaluation of the validity and utility of genetic testing for rare diseases.
Scott D Grosse, Lisa Kalman, Muin J Khoury. Adv Exp Med Biol 2010
37
10


A review of economic evaluations of genetic testing services and interventions (2004-2009).
Sandjar Djalalov, Zahra Musa, Michael Mendelson, Katherine Siminovitch, Jeffrey Hoch. Genet Med 2011
23
17

Cost effectiveness of pharmacogenomics: a critical and systematic review.
William B Wong, Josh J Carlson, Rahber Thariani, David L Veenstra. Pharmacoeconomics 2010
76
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.